Inventor
MULHERN MATHEW M
US13 patents
⚠️ This page may combine multiple inventors who share the name “MULHERN MATHEW M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
6 patentsUS10981923B2Apr 20, 2021
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
ABBVIE INC32 citations97
US9879018B2Jan 30, 2018
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl and solid state forms thereof
ABBVIE INC42 citations95
US12110298B2Oct 8, 2024
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
ABBVIE INC1 citations83
US9199992B2Dec 1, 2015
Processes for the preparation of an apoptosis-inducing agent
ABBVIE INC0 citations48
US9006438B2Apr 14, 2015
Processes for the preparation of an apoptosis-inducing agent
ABBVIE INC1 citations48
US9238652B2Jan 19, 2016
Processes for the preparation of an apoptosis-inducing agent
ABBVIE INC0 citations46
ABBOTT LAB
4 patentsUS7071182B2Jul 4, 2006
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
ABBOTT LAB6 citations62
US6921821B2Jul 26, 2005
Antagonists of melanin concentrating hormone receptor
ABBOTT LAB7 citations60
US7049307B2May 23, 2006
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
ABBOTT LAB1 citations51
US7834012B2Nov 16, 2010
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
ABBOTT LAB1 citations49